Skip to end of metadata
Go to start of metadata


ChairJean Duteau 

Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
Danielle BancroftBest Practice Software
Melva Peters Jenaker Consultingx
Jean Duteau (Chair)Duteau Designx
John Hatem (Scribe)Independent Consultantx
Scott Robertson Kaiser Permanentex
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCPx
Isaac VetterEpic
Smile CDRx
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDP
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealand
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborativex
Stephen ChuADHA
Tim McNeilSurescriptsx
Kim RobertsPharmacy HIT Collaborativex
Kent BulzaWell Health
Phung Matthews3Mx
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

Project Review

Project Proposals

Project Scope Statements

External Meeting Review

Catalog Updates (John Hatem)

  • - no meeting - no updates this week

Workflow Update (John Hatem) 

  • - Discussed Example Scenario updates to definitions and other changes.  No direct pharmacy impact. 
    • Also Contract resource scenarios discussed by Kathleen. 

Healthcare Product Update (John Hatem)

  • - Plan for updating trackers discussed; WGM agenda discussed
    • various trackers reviewed - see HCP minutes for specifics: BDP, Device
    • Product pattern tracker passed - FHIR-24643, two other trackers related, one is a duplicate:  14746, the other tracker is related but is focused on a "pattern" for queries - see 35874

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

NCPDP Updates (NCPDP Members)

All NCPDP Meeting information can be obtained at

WG18 Patient Consent TG:

    • specification is in the ballot for September
    • ballot comments to be reviewed


PDex Formulary (Corey)

    • Publication Request - approved by eVote
  • - will remove this topic from next week's minutes;  will be added in as needed for a future meeting.  

Pharmacist Consult Note (Scott)

    • Ballot content approved and content submitted
  • - no updates

Trackers - link to pharmacy unresolved Jira trackers (see trackers for details / resolutions)

  • Adherence:  Scott and Jean D will discuss narrative for this work. 
  • Waste: Scott has received some feedback he will bring that work to Pharmacy WG in the future.  A suggestion was made to bring this as a topic for the WGM.  

Any Other Business:

  • Shelly raised an issue related to the USCDI version 3 work - they are missing "directions for use".  
    • Jean provided a brief overview of the work and links - there may be some downstream work related to any updates to US Core Pharmacy content.  Expect they will reach out to Pharmacy as needed. 
    • Margaret reported she will be discussing ePrescribing with the USCDI folks this week.  

Next meeting: